ARCHIVES

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

This article is from The Cancer Letter archive.

Vol. 06 No. 21 | May 23, 1980

Download PDF Visit The Full Archive

Related Articles

NCI Study Find Farmers Using Herbicides At High Risk for Some Lymphomas

September 12, 1986

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

September 26, 1997

GAO Criticize NCI Contract Practices In Report On Cancer Control

July 25, 1980

NY Attorney General Sues Drug Companies Over Cancer Drug Pricing Deals

February 14, 2003

Pepper Committee, Impressed By Progress Reports, Promises Help With NCI Funding

June 29, 1979

Pittsburgh Investigates Use of Resources in Anonymous Mailing To Researchers

April 29, 1994